Crossmark

Unanticipated Cardiotoxicity Associated with Targeted Anticancer Therapy in Patients with Hematologic Malignancies Patients: Natural History and Risk Factors

Crossref DOI link: https://doi.org/10.1007/s12012-017-9429-8

Published Online: 2017-10-11

Published Print: 2018-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Shah, Chintan

Gong, Yan

Szady, Anita

Sun, Qian

Pepine, Carl J.

Langaee, Taimour

Lucas, Alexandra R.

Moreb, Jan S. https://orcid.org/0000-0001-9330-7500
Funding

Funding for this research was provided by:

National Institutes of Health (NIH- NHLBI-5 UM1 HL087366-10, 1R01HL132448-01, R01 HL033610-29, R01 HL056921-19)

NCATS-University of Florida Clinical and Translational Science (UL1TR001427)

PCORnet-OneFlorida (CDRN-1501-26692)
License Information

Text and Data Mining valid from 2017-10-11

Version of Record valid from 2017-10-11
More Information

Article History

First Online: 11 October 2017

Document is current

Any future updates will be listed below